P

Pulse Biosciences
D

PLSE

18.000
USD
0.36
(2.04%)
Market Closed
Volume
5,234
EPS
-1
Div Yield
-
P/E
-22
Market Cap
1,107,300,186
OverviewSignalsIdeasNews
Related Instruments
    B
    BCLI
    0.06500
    (5.75%)
    1.19500 USD
    C
    CLSD
    -0.05050
    (-4.81%)
    0.99950 USD
    D
    DOC
    -0.405
    (-1.91%)
    20.855 USD
    E
    ENTG
    -3.840
    (-3.78%)
    97.660 USD
    G
    GH
    -1.065
    (-3.53%)
    29.130 USD
    H
    HSKA
    2.130
    (2.41%)
    90.610 USD
    R
    RGEN
    -17.400
    (-12.22%)
    124.960 USD
    S
    SEER
    -0.10500
    (-4.34%)
    2.31500 USD
    T
    TECH
    -4.920
    (-6.79%)
    67.590 USD
    V
    VCYT
    -1.085
    (-2.93%)
    35.955 USD
    More
News

Title: Pulse Biosciences

Sector: Healthcare
Industry: Medical Instruments & Supplies
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.